Clinical use of human hepatocyte growth factor in the early detection of hellp syndrome

Gynecologic and Obstetric Investigation

Volumn 41, Issue 2, 1996, Pages 103-105

  Iioka, Hideaki ^a  

^a Tenri City Hospital   (Japan)

Author keywords

HELLP syndrome; Human hepatocyte growth factor

Indexed keywords

SCATTER FACTOR;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; SYMPTOM;

EID: 0030041760     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000292052     Document Type: Article

References (7)

1. Weinstein L: Syndrome of hemolysis, elevated liver enzyme and low platelet count: A severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-167.
2. Gohda E, Nakayama H, Tubouchi H: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res 1986:166:139.
3. Nakayama H, Tubouchi H, Gohda E: Stimulation of DNA synthesis in adult rat hepatocytes in primary culture by sera from patients with fulminant hepatic failure. Biomed Res 1985;6: 231.
4. Gohda E, Tubouchi H, Nakayama H: Purification and partial characterization of hepatocyte growth factor from plasma of patients with fulminant hepatic failure. J Clin Invest 1988;81: 414.
5. Nakamura T, Nishizawa T, Hagiya M: Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440.
6. Tubouchi H, Hirono S, Gohda E: Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology 1989;9:875.
7. Nakayama M: Report about diagnostic criteria of EPH-gestosis. Nippon Sanka Fujinka Gak-kai Zasshi 1990;42:220.